Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis
- PMID: 25973276
- PMCID: PMC4418003
- DOI: 10.1155/2015/829439
Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis
Abstract
Introduction. Prostate cancer is the most common cancer among men in USA. The surgical outcomes of prostate cancer remain inconsistent. Barriers such as socioeconomic factors may play a role in patients' decision of refusing recommended cancer-directed surgery. Methods. The Nebraska Cancer Registry data was used to calculate the proportion of prostate cancer patients recommended the cancer-directed surgery and the surgery refusal rate. Multivariate logistic regression was applied to analyze the socioeconomic indicators that were related to the refusal of surgery. Results. From 1995 to 2012, 14,876 prostate cancer patients were recommended to undergo the cancer-directed surgery in Nebraska, and 576 of them refused the surgery. The overall refusal rate of surgery was 3.9% over the 18 years. Patients with early-stage prostate cancer were more likely to refuse the surgery. Patients who were Black, single, or covered by Medicaid/Medicare had increased odds of refusing the surgery. Conclusion. Socioeconomic factors were related to the refusal of recommended surgical treatment for prostate cancer. Such barriers should be addressed to improve the utilization of surgical treatment and patients' well-being.
Figures
Similar articles
-
Refusal of Cancer-Directed Surgery in Patients with Colon Cancer: Risk Factors of Refusal and Survival Data.Ann Surg Oncol. 2021 Feb;28(2):606-616. doi: 10.1245/s10434-020-08783-1. Epub 2020 Jul 7. Ann Surg Oncol. 2021. PMID: 32638164
-
Treatment of stage I-III rectal cancer: Who is refusing surgery?J Surg Oncol. 2020 May;121(6):990-1000. doi: 10.1002/jso.25873. Epub 2020 Feb 23. J Surg Oncol. 2020. PMID: 32090341
-
Refusal of Cancer-Directed Surgery in Head and Neck Squamous Cell Carcinoma Patients.Laryngoscope. 2019 Jun;129(6):1368-1373. doi: 10.1002/lary.27116. Epub 2018 Aug 2. Laryngoscope. 2019. PMID: 30070700
-
Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.J Surg Oncol. 2020 Jun;121(8):1306-1313. doi: 10.1002/jso.25917. Epub 2020 Mar 29. J Surg Oncol. 2020. PMID: 32227344
-
Survival after refusal of surgical treatment for locally advanced laryngeal cancer.Oral Oncol. 2017 Aug;71:34-40. doi: 10.1016/j.oraloncology.2017.05.019. Epub 2017 Jun 6. Oral Oncol. 2017. PMID: 28688688
Cited by
-
Factors Associated With Patient's Refusal of Recommended Cancer Surgery: Based on Surveillance, Epidemiology, and End Results.Front Public Health. 2022 Jan 17;9:785602. doi: 10.3389/fpubh.2021.785602. eCollection 2021. Front Public Health. 2022. PMID: 35111717 Free PMC article.
-
Refusal of Surgery in Pituitary Adenoma Patients: A Population-Based Analysis.Cancers (Basel). 2022 Oct 30;14(21):5348. doi: 10.3390/cancers14215348. Cancers (Basel). 2022. PMID: 36358767 Free PMC article.
-
A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.Sci Rep. 2024 Apr 25;14(1):9494. doi: 10.1038/s41598-024-60180-w. Sci Rep. 2024. PMID: 38664545 Free PMC article.
-
Age as a Barrier to Surgical Stabilization of Rib Fractures in Patients with Flail Chest.Am Surg. 2023 Apr;89(4):927-934. doi: 10.1177/00031348211047490. Epub 2021 Nov 3. Am Surg. 2023. PMID: 34732075 Free PMC article.
References
-
- US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-Based Report. Atlanta, Ga, USA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014.
-
- Surveillance Epidemiology and End Results Program. Cancer of the Prostate—SEER Stat Fact Sheets. Surveillance Epidemiology and End Results Program; 2015. http://seer.cancer.gov/statfacts/html/prost.html.
-
- National Cancer Institute. Prostate Cancer Treatment (PDQ) 2015. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessi....
-
- Moon T. D., Brawer M. K., Wilt T. J. Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee. Journal of the National Cancer Institute. Monographs. 1994;(19):69–71. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources